Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The brain-derived neurotrophic factor receptor refers to the cell surface receptors that bind and mediate the effects of brain-derived neurotrophic factor (BDNF). The two main receptors are TrkB, a high-affinity tyrosine kinase receptor, and p75NTR/LNGFR, a low-affinity pan-neurotrophin receptor. TrkB activation promotes neuronal survival, differentiation, and synaptic plasticity, while p75NTR can induce apoptosis or neurite outgrowth depending on the cellular context. Dysregulation of these receptors is implicated in neurological diseases.
Mature BDNF binds to TrkB, activating intracellular signaling cascades (PI3K/Akt, MAPK/ERK, PLCγ) promoting neuronal survival and plasticity. ProBDNF and mature BDNF can bind to p75NTR, triggering apoptosis or neurite outgrowth depending on cellular context and co-receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-Derived Neurotrophic Factor Receptor (BDNF receptor).